H Lundbeck A/S S/Adr

(HLUYY)

By |

Profile

Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system, or CNS, drugs worldwide, including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, and Onfi for epilepsy.

Contact Information

Website: www.lundbeck.com
Email: palo@lundbeck.com
Main Phone: +45 36301311
Address: Ottiliavej 9
City / Town: Valby
Country: DNK
Postal Code: 2500

Issuer Information

Exchange: OTO
Employees: 5119
$ 41.95 $ 0. (0.00%)
Last Price 41.95 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 41.95
Last Trade Volume 141 52 Wk Hi 73.90 52 Wk Low 38.65
Market Cap 8.4 bi Ex-Div Date Div Rate 0.95 Yield 2.2610
Shares 199,098,422.00 EPS (TTM) 2.97 PE Ratio 13.70 Exchange OTCPK
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 86 86 86 86
Low Target Price Estimate 86 86 86 86
Mean Target Price Estimate 86 86 86 86
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 12/10/13 12/10/13 12/10/13 12/10/13
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 3 3 3 3